Literature DB >> 6833664

Nonsurgical reperfusion in evolving myocardial infarction.

W Ganz, I Geft, J Maddahi, D Berman, Y Charuzi, P K Shah, H J Swan.   

Abstract

Nonsurgical recanalization of the occluded coronary artery has been performed in patients with evolving myocardial infarction since the late 1970s by intracoronary administration of thrombolytic agents at the ostium of the occluded artery or directly to the site of occlusion. The authors review the basic concepts underlying intracoronary thrombolysis, the method applied at their institution and the clinical results. Reperfusion of totally occluded arteries or termination of the ischemic state in subtotally occluded arteries was achieved in 71 (87.7%) of 81 patients. Reocclusion occurred in four patients, in three of these at a time when anticoagulation became temporarily ineffective, emphasizing the need for uninterrupted anticoagulation with a partial thromboplastin time longer than 80 seconds. Thallium scintigraphic studies before and after reperfusion showed a decrease in defect, indicating myocardial salvage, in the successful cases but not in failures or untreated control subjects. A decrease in thallium-201 defect was followed by improvement of regional wall motion and usually also left ventricular ejection fraction. Three of the patients with an unsuccessful result and one patient with a successful result died. Bypass surgery was performed electively in 18 patients because of multiple vessel involvement. Intracoronary thrombolysis appears to be a relatively safe and promising procedure. A large controlled study will be needed for definitive assessment of its role in the management of acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833664     DOI: 10.1016/s0735-1097(83)80136-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Intravenous short-term infusion of streptokinase in acute myocardial infarction.

Authors:  R Schröder
Journal:  Tex Heart Inst J       Date:  1984-03

2.  Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors:  P Golino; J T Willerson
Journal:  Tex Heart Inst J       Date:  1991

3.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

4.  Issues Regarding the Use of Heparin Following Streptokinase Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

5.  Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction.

Authors:  C de Zwaan; G M Willems; F Vermeer; J Res; F W Verheugt; A van der Laarse; M L Simoons; J Lubsen; W T Hermens
Journal:  Br Heart J       Date:  1988-02

6.  Intracoronary thrombolysis in acute myocardial infarction.

Authors:  N Brooks
Journal:  Br Heart J       Date:  1983-11

7.  Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin.

Authors:  G Melandri; A Branzi; F Semprini; V Cervi; N Galiè; B Magnani
Journal:  Br Heart J       Date:  1990-08

8.  Are enzymatic tests good indicators of coronary reperfusion?

Authors:  H A Bosker; A van der Laarse; V M Cats; A V Bruschke
Journal:  Br Heart J       Date:  1992-02

9.  Hemopericardium and tamponade following intracoronary thrombolysis with streptokinase.

Authors:  W E Walker; F Fuentes; P R Adams; R C Kuykendall; J D McArthur; A P Weiland
Journal:  Tex Heart Inst J       Date:  1985-06

10.  Augmented uptake of 2-C-14-D-deoxyglucose in reversibly-injured myocardium.

Authors:  J A Bianco; J Bakanauskas; M Carlson; S Jones; A Moring; J S Alpert; V Klassen
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.